Aimovig
(erenumab) Novartis

Composition:

• Available in solution for injection with each pre-filled pen contains 70 mg of erenumab

Indication:

• For the prophylaxis of migraine in adults who have at least 4 migraine days per month

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.